• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 435447 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1416844796 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1416844796 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Stock Investors Sell Off Shares of AMAG Pharmaceuticals, Down 2.1%

Published on Mon, 02/04/2013 - 11:32
By Robert Cotter

One of today's notable stocks in decline is AMAG Pharmaceuticals (NASDAQ:AMAG), down 2.1% to $15.93. The S&P is trading lower by 0.7% to 1,503 and the Dow is trading 0.8% lower to 13,900.

AMAG Pharmaceuticals, Inc., a biopharmaceutical company, utilizes its proprietary nanoparticle technology for the development and commercialization of therapeutic iron compounds to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease.

In the past 52 weeks, shares of AMAG Pharmaceuticals have traded between a low of $12.43 and a high of $18.50 and are now at $15.93, which is 28% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.9% while the 200-day MA has remained constant.

Potential upside of 4.6% exists for AMAG Pharmaceuticals, based on a current level of $15.93 and analysts' average consensus price target of $16.67. The stock should find initial support at its 200-day moving average (MA) of $15.44 and further support at its 50-day MA of $15.28.

By Robert Cotter
rcotter@fnno.com

Latest News from FNNO

Shares of Medifast Under Pressure, Down ...

Medifast (NYSE:MED) is one of today's biggest movers, down 5.9% to $29.06. The S&P is ...

Stock Investors Bid Up Shares of CardioN...

CardioNet (NASDAQ:BEAT), a company whose shares are moving quickly, is trading 6.8% hig ...

Stock Investors Bid Up Shares of Ariad P...

Ariad Pharmaceuticals (NASDAQ:ARIA) is one of today's notable stocks on the rise, up 10 ...

Buyers Accumulate Shares of Platinum Und...

One of today's stocks on the move is Platinum Underwriters Holdings (NYSE:PTP), up 19.4 ...

Hot Stock: XOMA, Shares Gain 6.0% (XOMA)...

XOMA (NASDAQ:XOMA) is one of today's best performing low-priced stocks, up 6.0% to $4.8 ...

Watch for Shares of Meredith (MDP) to Ap...

Shares of Meredith (NYSE:MDP) have bullishly opened above the pivot of $51.00 today and ...

Next Resistance Level for Public Storage...

Shares of Public Storage (NYSE:PSA) have bullishly opened above the pivot of $185.21 to ...

Watch for Shares of M&T Bank (MTB) to Ap...

Shares of M&T Bank (NYSE:MTB) have bullishly opened above the pivot of $125.06 today an ...